Sudarshan Pharma Industries Limited: Issue of Securities
Issue of Securities - Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities - In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising of funds through issue and allotment of Convertible Warrants upto an amount not exceeding Rs.72 Crores, each warrant convertible into 1 equity share of Re1/- each, on a preferential basis to Mr. Hemal Mehta and Mr.
SectorPharma & Healthcare
Value₹72 cr
Sources
Open in the live tracker →Related deals
- Paras Healthcare Limited: Updates30 Oct 2026
- Natco Pharma Limited: Copy of Newspaper Publication29 Oct 2026
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026